The purpose of this study is to design and Beta test the Life at 100.4, an immersive social virtual reality education tool, with an anticipated 5 patient-caregiver-provider triads.Patients at Yale Pediatric Hematology and Oncology with a new oncologic diagnosis and their caregivers will be eligible for enrollment. Investigators will determine the feasibility and acceptability of implementing Life at 100.4 using validated measures.
Newly diagnosed with a malignancy or bone marrow failure condition
Planned to receive chemotherapy and receive a central line
Medical contraindication to virtual reality including head wounds and history of seizure with flashing lights
No plan to receive chemotherapy
Yale University
Lead sponsor
The Glimpse Group Inc
Collaborator
National Institute of Nursing Research (NINR)
Collaborator